Abiopharma

Clinical trial NCT06049212: primary completion date: 2026-06-30 → 2026-12-31.

Clinical trial NCT06930508 updates: 1. completion date: 2026-07-31 → 2026-12-31 2. primary completion date: 2026-07-31 → 2026-10-31

Clinical trial NCT06052631: start date: 2026-08-10 → 2026-08-11.

Clinical trial NCT06092476 updates: 1. status: RECRUITING → ACTIVE_NOT_RECRUITING 2. completion date: 2027-07-01 → 2028-01-01 3. primary completion date: 2027-01-01 → 2027-03-01

Clinical trial NCT07623200 updates: 1. status: NOT_YET_RECRUITING → RECRUITING 2. start date: 2026-07-31 → 2026-09-08

Clinical trial NCT06534983: status: RECRUITING → ACTIVE_NOT_RECRUITING.

Clinical trial NCT04092010: status: RECRUITING → ACTIVE_NOT_RECRUITING.

Clinical trial NCT07564596 updates: 1. status: NOT_YET_RECRUITING → RECRUITING 2. start date: 2026-06-01 → 2026-06-30

Clinical trial NCT05543616 updates: 1. status: ACTIVE_NOT_RECRUITING → COMPLETED 2. completion date: 2026-07-23 → 2026-07-10 3. primary completion date: 2026-07-23 → 2026-07-10 4. enrollment: 4292 → 4338 participants 5. enrollment type: ESTIMATED → ACTUAL

Clinical trial NCT07493304: start date: 2026-06-30 → 2026-08-31.

Clinical trial NCT07317934: enrollment: 332 → 388 participants.

Clinical trial NCT07643766 updates: 1. status: NOT_YET_RECRUITING → RECRUITING 2. start date: 2026-06-01 → 2026-06-29

Clinical trial NCT05107115: enrollment: 161 → 160 participants.

Clinical trial NCT02461420: enrollment: 205 → 207 participants.

Clinical trial NCT05232916 updates: 1. start date: 2022-08-11 → 2022-12-16 2. completion date: 2026-12-01 → 2031-12-01 3. primary completion date: 2026-12-01 → 2031-12-01 4. enrollment: 750 → 2250 participants